Background: Acute respiratory distress syndrome (ARDS) is a serious
condition which necessitates admission to an intensive care unit, is linked to a
high rate of hospital death. Refractory hypoxemia is the most significant
pathophysiological characteristic of ARDS. Airway pressure release
ventilation (APRV) characterized as a constant positive airway pressure with
intermittent release phase. It also has a good effect in patient with acute
respiratory distress syndrome (ARDS) therapy paradigm. This study set out
to assess the effectiveness of APRD in raising oxygenation levels and
reducing death rates in severely ill ARDS patient. Method: The study was
carried out in compliance with PRISMA criteria. From 2000 to 2022, we
looked for researches in Embase, PubMed, the Cochrane Library and Web of
Science. Every study that addressed the impact of APRV on adults suffering
from ARDS was included. The oxygenation status was our main outcome.
Mortality and the length of stay (LOS) in the critical care unit were the
secondary outcomes. Results: Six studies were included in this systematic
review. Tidal volume was set in 4 to 6 mL/kg in four investigations that
evaluated APRV to traditional modes that employ low tidal volume
technique. In the other two investigations, tidal volume larger than 6 mL/kg
was employed to test APRV to synchronized intermittent mandatory
breathing. All trials provided the mortality result; and five studies reported
intensive care unit LOS. Conclusion: This study concludes that APRV use have
shortened the LOS in the critical care unit and boosted oxygenation on day
three.
Keywords: Mechanical ventilation, acute respiratory distress syndrome,
airway pressure release ventilation
